Tony McRay – Trademark Portfolio

Entity Type: 01

Tony McRay holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 7 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include S+S COMPLEX, FEARED X LOVED, LEGENDS & LEGACIES, and BEAUTIFUL LIES UGLY TRUTHS. The owner is based in Spring, TX.

6714 Lilac Meadows

Spring, TX 77379

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tony McRay's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (7 filings)

Clothing, footwear, headgear

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Tony McRay have?

Tony McRay has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned.

What trademark classes does Tony McRay file in?

Tony McRay files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 25 covers clothing, footwear, headgear.

What are Tony McRay's most well-known trademarks?

Tony McRay's registered trademark portfolio includes well-known marks such as S+S COMPLEX, FEARED X LOVED, LEGENDS & LEGACIES, and BEAUTIFUL LIES UGLY TRUTHS. These are among 6 currently registered trademarks in the portfolio.

What is Tony McRay's trademark registration success rate?

Tony McRay has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.